What we are looking for

We are seeking opportunities in our 5 areas of research and development:



We are interested in all innovative “best-in-class” products, from the target stage to late-stage clinical trials, provided they bring true therapeutic innovation to areas of unmet needs.


We are also interested in licensing marketed, or near-market, products that complement our existing portfolio.


Out-licensing: We are looking for partners in the United States and Japan to license some of our drug candidates and medicinal products, and global partners for non-strategic products.


What types of agreements?

  • Global rights with or without the United States and Japan
  • Local and regional agreements
  • R&D collaborations starting immediately or after option exercise





We currently have more than 51 active alliances with biotech and pharmaceutical companies across all our areas of activity: